Elanco Animal Health Incorporated

NYSE:ELAN

16.48 (USD) • At close August 7, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q1
Revenue 1,2411,1931,0201,0301,1841,2051,0351,0681,0571,2579881,0281,1771,2251,1131,1311,2791,2421,139.7889.6586.3657.7787771.3781.6731.1799.3761.1770.2736.2754.3697.1718.8718.8
Cost of Revenue 528509501625626515516487434494448472484509512502551569596.2441.8295.9332.7410.1360.4356343.8412.5369.8431.5360405376.2343.1343.1
Gross Profit 713684389405558690519581623763540556693716601629728673543.5447.8290.4325376.9410.9425.6387.3386.8391.3338.7376.2349.3320.9375.7375.7
Gross Profit Ratio 0.5750.5730.3810.3930.4710.5730.5010.5440.5890.6070.5470.5410.5890.5840.540.5560.5690.5420.4770.5030.4950.4940.4790.5330.5450.530.4840.5140.440.5110.4630.460.5230.523
Reseach & Development Expenses 929481878987798681818078828192949489112.788.159.466.867.369.968.864.161.158.961.465.26261.963.9563.95
General & Administrative Expenses 000000850001020008100018200182185.9192.3200.9181.1185.10000000
Selling & Marketing Expenses 000000207000201000248000611000000000000000
SG&A 400341300323354337292313353327303298343320329342385348374.1277.7162.8182185.9192.3200.9181.1185.1179191.1180196.8194.7194.2194.2
Other Expenses 012800-2-9-34-9-231341301281331373-11314716.6114.947.9-1.1-6.3-14.6-3.9-2.6-25.7-13.5-8.8-1.901.900
Operating Expenses 492563381410443557509539570542513504558538560577608584650.5461.4271.2300.4304.6312.9319294.2296.3286.6301.9294.4319308.2409.7409.7
Operating Income 2211218-5115133-244253212644135169-665212089-107-13.619.224.672.398106.693.190.5104.736.881.830.312.762.8562.85
Operating Income Ratio 0.1780.1010.008-0.0050.0970.11-0.0230.0390.050.1690.0060.0430.1150.138-0.0590.0460.0940.072-0.094-0.0150.0330.0370.0920.1270.1360.1270.1130.1380.0480.1110.040.0180.0870.087
Total Other Income Expenses Net -196-61-59564-147-121-137-1,139-132-113-185-94-153-107-55-182-356-169-211.1-195.4-96.3-92.4-76.6-110.5-56.4-48.3-92.7-25.9-76.8-4.3-185.7-21.8-96.85-96.85
Income Before Tax 2560-51559-3212-127-1,097-79108-88-42-1871-121-130-236-80-318.1-209-77.1-67.8-4.3-12.550.244.8-2.278.8-4077.5-155.4-9.1-34-34
Income Before Tax Ratio 0.020.05-0.050.543-0.0270.01-0.123-1.027-0.0750.086-0.089-0.041-0.0150.058-0.109-0.115-0.185-0.064-0.279-0.235-0.132-0.103-0.005-0.0160.0640.061-0.0030.104-0.0520.105-0.206-0.013-0.047-0.047
Income Tax Expense 14-7-4319518-2014-1185-347423-24-26-26-194.7-74-23.9-18.75.2-22.514.313.3-18.618.622.84.86.111.630.2530.25
Net Income 1167-8364-5032-141-1,096-97103-54-49-2251-97-104-210-61-322.8-135-53.2-49.1-9.51035.931.516.460.2-62.872.7-161.5-20.7-64.25-64.25
Net Income Ratio 0.0090.056-0.0080.353-0.0420.027-0.136-1.026-0.0920.082-0.055-0.048-0.0190.042-0.087-0.092-0.164-0.049-0.283-0.152-0.091-0.075-0.0120.0130.0460.0430.0210.079-0.0820.099-0.214-0.03-0.089-0.089
EPS 0.020.14-0.0160.74-0.10.06-0.29-2.22-0.20.21-0.11-0.1-0.0450.1-0.2-0.21-0.43-0.13-0.66-0.29-0.13-0.12-0.0260.030.10.090.040.16-0.180.2-0.45-0.057-0.18-0.18
EPS Diluted 0.020.13-0.0160.73-0.10.06-0.29-2.22-0.20.21-0.11-0.1-0.0450.1-0.2-0.21-0.43-0.13-0.66-0.29-0.13-0.12-0.0250.030.10.090.040.16-0.180.2-0.44-0.057-0.18-0.18
EBITDA 221261175787195299111-852230394146217304352114100293293-34.7-28.619.224.697.8176.7148.1140.892.5177.435.3156.1117.487.9140.9140.9
EBITDA Ratio 0.1780.2190.1720.7640.1650.2480.107-0.7980.2180.3130.1480.2110.2580.2870.1020.0880.2290.236-0.03-0.0320.0330.0370.1240.2290.1890.1930.1160.2330.0460.2120.1560.1260.1960.196